News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
King Pharmaceuticals®, Inc. Posts Q4 Loss on Charge, Lower Sales
February 26, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
BOSTON, Feb 26 (Reuters) - King Pharmaceuticals Inc posted a fourth-quarter loss on Thursday as sales of its blood pressure drug fell and it took an acquisition-related charge.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
People
Sanofi Shares Decline as Paul Hudson Removed as CEO, Making Way For Merck KGaA’s Belén Garijo
February 12, 2026
·
2 min read
·
Annalee Armstrong
Insights
Digital Pathology, AI and the Future of ADCs and HER2 Cancer Treatment
February 12, 2026
·
1 min read
·
Jennifer Smith-Parker
GLP-1
Oral Wegovy Brings in Thousands of New GLP-1 Patients
February 12, 2026
·
1 min read
·
Tristan Manalac
Manufacturing
PharmaEssentia Shores up Supply with $46M Investment in Puerto Rico Plant
February 11, 2026
·
2 min read
·
Nick Paul Taylor
